Abstract
Information on the health-related consequences of rare chromosome disorders is often limited, posing challenges for both patients and their families. The Chromosome 6 Project aims to bridge this knowledge gap for structural aberrations involving chromosome 6 by providing parents of affected children with information on the expected phenotypes of their child. To achieve this, detailed phenotype and genotype data is collected directly from parents worldwide and supplemented with data from literature reports, resulting thus far in a dataset of over 500 individuals. This comprehensive data pool was used to develop Del2Phen, a software tool introduced in this paper that generates aberration-specific phenotype information for chromosome disorders. Del2Phen identifies individuals with a deletion or duplication similar to that of a new patient (index) and produces a clinical description for the index based on phenotypic features observed in these genotypically similar individuals. Genotypic similarity is determined using existing knowledge on the haploinsufficiency effect of genes and established gene-phenotype relationships. The optimal genotypic similarity parameters for chromosome 6 deletions were evaluated, which lead to thorough and reliable clinical descriptions based on sufficiently large groups of individuals with highly similar deletions. Although currently applied to and optimized for chromosome 6 deletions, Del2Phen can be used on deletions involving other chromosomes and is easily adapted for use on duplications, provided sufficient data is available. Del2Phen can already be used to expedite data analysis for chromosome disorders, thus aiding healthcare professionals in providing clinical care. Lastly, this tool will also be integrated into an interactive website aimed at parents of children with a chromosome 6 aberration, providing them with essential health information in an efficient and timely manner.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://github.com/Chromosome-6-Project/Del2Phen
Funding Statement
ER and AE are recipients of a JSM MD/PhD scholarship from the University Medical Center Groningen. This research was additionally supported by a grant from ZonMw (113312101) and crowdfunding organised by Chromosome 6 parents. MAS is recipient of a VIDI grant (917.164.455) from the Netherlands Organisation for Scientific Research (NWO).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The accredited Medical Ethics Review Committee of the University Medical Center Groningen waived ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
7. Data Availability Statement
The phenotype and genotype data of Chromosome 6 Project participants are stored in the secure in- house Chromosome 6 database. The data is also available open-access on DECIPHER (www.deciphergenomics.org)19 under the following patient IDs: 425375, 425379-425388, 426261, 433748-433760, 489709-489746 and 524537-524630.